February 23, 2025 - 11:30

Today's Capricorn horoscope reveals promising developments in your career and finances. As the stars align favorably, Capricorns can expect significant progress in their professional endeavors. This is an ideal time to showcase your skills and take on new responsibilities that could lead to advancement. Networking will play a crucial role, so don’t hesitate to connect with colleagues and industry professionals.
Financially, the forecast looks bright. You may receive unexpected gains or opportunities that could enhance your financial stability. It’s advisable to remain prudent with your spending while considering potential investments that align with your long-term goals.
In matters of love, the cosmic energies suggest a period of reflection and deeper connection with your partner. If single, this could be a time for self-discovery, allowing you to understand what you truly desire in a relationship. Embrace the changes and trust that the universe is guiding you toward success in all areas of your life.
May 14, 2026 - 00:55
Aeluma Announces Third Quarter Fiscal 2026 Financial ResultsAeluma, Inc., a company specializing in compound semiconductor technologies, has released its financial results for the third quarter of fiscal year 2026. The report comes alongside several major...
May 13, 2026 - 11:31
MCK Q1 Deep Dive: Revenue Misses Analyst Expectations as Margin Initiatives ContinueHealthcare distributor McKesson reported first-quarter earnings that missed revenue expectations, though the company continued to push ahead with margin-focused initiatives. For the quarter ending...
May 12, 2026 - 23:07
Prudential Financial Declares Quarterly Dividend on Common StockNEWARK, N.J., May 12, 2026 -- Prudential Financial, Inc. has declared a quarterly dividend of $1.40 per share on its common stock. The payment is scheduled for June 11, 2026, and will go to...
May 12, 2026 - 03:06
Cellectis Reports First Quarter 2026 Financial ResultsCellectis has announced its financial results for the first quarter of 2026, alongside updates on its clinical pipeline and preclinical research programs. The company is advancing its pivotal...